EXOSTEMTECH CO LTD has a total of 20 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are SUZHOU SIRNAOMICS BIOPHARMACEUTICALS CO LTD, CELL MED RES GMBH and OLOGY BIOSERVICES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 6 | |
#3 | Australia | 2 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Brazil | 1 | |
#6 | China | 1 | |
#7 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Foods and drinks |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Microorganisms | |
#4 | Specific use of cosmetics | |
#5 | Foods | |
#6 | Special foods |
# | Name | Total Patents |
---|---|---|
#1 | Cho Yong Woo | 16 |
#2 | Choi Ji Suk | 16 |
#3 | Kim Eun Ji | 8 |
#4 | Yoon Hwa In | 8 |
#5 | Lee Kyoung-Soo | 8 |
#6 | Kim Jun Sung | 7 |
#7 | Yang Seong Hyun | 7 |
#8 | Lee Hansang | 2 |
#9 | Heo Roun | 2 |
#10 | Choi Young Chan | 2 |
Publication | Filing date | Title |
---|---|---|
US2020316131A1 | Pharmaceutical composition for treating drug-resistant cancer comprising exosomes derived from differentiating stem cells as an active ingredient | |
WO2020022541A1 | Composition comprising exosome as effective ingredient for prevention or treatment of acute liver failure | |
WO2018226051A2 | Serum-free medium composition for culturing cells including exosome derived from human stem cell | |
EP3189828A1 | Composition for differentiation induction of adipocyte containing stem cell-derived exosome, regeneration of adipose tissue, and skin whitening or wrinkle improvement |